Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Ana Fernandez-Bustamante to Neuromuscular Blockade

This is a "connection" page, showing publications Ana Fernandez-Bustamante has written about Neuromuscular Blockade.

 
Connection Strength
  
 
 
0.844
  
  1. Stair C, Fernandez-Bustamante A. Sugammadex, the first selective relaxant binding agent for neuromuscular block reversal. Drugs Today (Barc). 2012 Jun; 48(6):405-13.
    View in: PubMed
    Score: 0.364
  2. Krause M, Fernandez-Bustamante A, Bartels K. In Response. Anesth Analg. 2020 08; 131(2):e74-e75.
    View in: PubMed
    Score: 0.160
  3. Krause M, Fernandez-Bustamante A, Bartels K. In Response. Anesth Analg. 2020 08; 131(2):e79-e80.
    View in: PubMed
    Score: 0.160
  4. Krause M, McWilliams SK, Bullard KJ, Mayes LM, Jameson LC, Mikulich-Gilbertson SK, Fernandez-Bustamante A, Bartels K. Neostigmine Versus Sugammadex for Reversal of Neuromuscular Blockade and Effects on Reintubation for Respiratory Failure or Newly Initiated Noninvasive Ventilation: An Interrupted Time Series Design. Anesth Analg. 2020 07; 131(1):141-151.
    View in: PubMed
    Score: 0.159
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)